Extract notice to the Minister
Cosentyx (indications diverses)
Common name / Subject : sécukinumab
Name of the manufacturer : Novartis
Form : Sol. Inj. S.C.
Dosage : 150 mg/ml (2 ml)
Name of the manufacturer : Novartis
Form : Sol. Inj. S.C.
Dosage : 150 mg/ml (2 ml)
Indication : Indications diverses
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
Surseoir à la décision (2026-04-01)
Evaluation published on April 01, 2026
INESSSid: 28477
Recevable on September 29, 2025